• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bristol-Myers Squibb

Bristol-Myers Squibb

Bristol-Myers Squibb Company BMY

Last Price$55.48Day Change (%)-1.77%
Open Price$56.26Day Change ($)-1.00
Day Range55.40–56.3152-Week Range55.02–77.12

As of Mon 9/26/2016 7:58:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

    Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

  2. Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESMO 2016 Congress Highlights

    Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESMO 2016 Congress Highlights

  3. Bristol-Myers Squibb to Take Part in Leerink Partners Immuno-Oncology Roundtable Conference

    Bristol-Myers Squibb to Take Part in Leerink Partners Immuno-Oncology Roundtable Conference

  4. UPDATE: Allergan is paying a stunning 500% premium to buy a clinical-stage biotech

    UPDATE: Allergan is paying a stunning 500% premium to buy a clinical-stage biotech

  5. UPDATE: Yes, you are paying a lot more for prescription drugs (and not just the EpiPen)

    UPDATE: Yes, you are paying a lot more for prescription drugs (and not just the EpiPen)

  6. UPDATE: Yes, you are paying a lot more for prescription drugs (and not just the EpiPen)

    UPDATE: Yes, you are paying a lot more for prescription drugs (and not just the EpiPen)

  7. Yes, you are paying more a lot more for prescription drugs (and not just the EpiPen)

    Yes, you are paying more a lot more for prescription drugs (and not just the EpiPen)

  8. Mylan top executive pay was second-highest in industry just as company raised EpiPen prices

    Mylan top executive pay was second-highest in industry just as company raised EpiPen prices

  9. Scientists Honored for Hep C Research

    Scientists Honored for Hep C Research

  10. Global Urological Cancer Market Forecast to 2022 - Key Players are Novartis, Pfizer & AstraZeneca - Research and Markets

    Global Urological Cancer Market Forecast to 2022 - Key Players are Novartis, Pfizer & AstraZeneca - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.